A Study of Solifenacin Succinate Compared to Tolterodine in Patients With Overactive Bladder

Astellas

Status and phase: Completed; Phase 3

Conditions: Overactive Bladder

Treatments: Drug: Solifenacin succinate

Study type: Interventional

Funder types: Industry

Identifiers

NCT00189800

90502/KOoTD01

Details and patient eligibility

About

The purpose of this study is to ascertain the clinical results of solifenacin succinate of PIII study conducted in the original country using Korean patients with an overactive bladder.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Symptoms of overactive bladder
• Must be able to complete the micturition diary

Exclusion criteria

• Pregnant or lactating
• Clinically significant outflow obstruction
• Significant post void residual urine
• Significant stress incontinence
• Urinary tract infection
• Chronic inflammation
• Bladder stones
• Previous pelvic radiation therapy
• Previous or current malignant disease of the pelvic organs
• Uncontrolled narrow angle glaucoma
• Urinary or gastric retention
• Electrostimulation therapy
• Bladder training
• Diabetic neuropathy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind